Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Preferred Shares Issued (2019)

Historic Preferred Shares Issued for Beam Therapeutics (BEAM) over the last 1 years, with Q1 2019 value amounting to $37.9 million.

  • Beam Therapeutics' Preferred Shares Issued changed N/A to $37.9 million in Q1 2019 from the same period last year, while for Dec 2019 it was $37.9 million, marking a year-over-year change of. This contributed to the annual value of $37.9 million for FY2019, which is N/A changed from last year.
  • According to the latest figures from Q1 2019, Beam Therapeutics' Preferred Shares Issued is $37.9 million.
  • In the past 5 years, Beam Therapeutics' Preferred Shares Issued ranged from a high of $37.9 million in Q1 2019 and a low of $37.9 million during Q1 2019